Recent Finacing
Recent Raise
RemeGen discovers, develops, manufactures, and commercializes biologic drugs—fusion proteins and antibody‑drug conjugates—targeting autoimmune diseases, oncology, and ophthalmology, with multiple Phase II/III and pivotal programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
